GLEN ALLEN, Va. - Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), a biopharmaceutical company specializing in addiction treatment with a current market capitalization of $5 million, has been granted a new ...
The EU executive also ditched a plan which would require Meta Platforms' WhatsApp and Microsoft unit Skype to be subjected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback